塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/07/18 | 5,752 | 5,796 | 5,714 | 5,714 | +26 | +0.5% | 1,011,400 |
2018/07/17 | 5,553 | 5,733 | 5,550 | 5,688 | +136 | +2.4% | 1,423,300 |
2018/07/13 | 5,536 | 5,595 | 5,507 | 5,552 | +13 | +0.2% | 1,366,500 |
2018/07/12 | 5,575 | 5,606 | 5,529 | 5,539 | +23 | +0.4% | 1,081,600 |
2018/07/11 | 5,590 | 5,592 | 5,495 | 5,516 | -89 | -1.6% | 1,169,100 |
2018/07/10 | 5,595 | 5,648 | 5,581 | 5,605 | +8 | +0.1% | 1,045,400 |
2018/07/09 | 5,566 | 5,626 | 5,559 | 5,597 | +38 | +0.7% | 735,100 |
2018/07/06 | 5,480 | 5,604 | 5,474 | 5,559 | +106 | +1.9% | 1,420,500 |
2018/07/05 | 5,519 | 5,529 | 5,410 | 5,453 | -42 | -0.8% | 1,510,500 |
2018/07/04 | 5,468 | 5,515 | 5,437 | 5,495 | +3 | +0.1% | 815,800 |
2018/07/03 | 5,507 | 5,535 | 5,437 | 5,492 | +20 | +0.4% | 1,485,200 |
2018/07/02 | 5,648 | 5,651 | 5,469 | 5,472 | -219 | -3.8% | 1,403,300 |
2018/06/29 | 5,672 | 5,699 | 5,613 | 5,691 | +59 | +1% | 1,108,800 |
2018/06/28 | 5,636 | 5,654 | 5,590 | 5,632 | -54 | -0.9% | 1,058,400 |
2018/06/27 | 5,669 | 5,728 | 5,650 | 5,686 | +44 | +0.8% | 1,586,500 |
2018/06/26 | 5,610 | 5,649 | 5,566 | 5,642 | +32 | +0.6% | 793,000 |
2018/06/25 | 5,710 | 5,727 | 5,606 | 5,610 | -57 | -1% | 890,300 |
2018/06/22 | 5,710 | 5,745 | 5,625 | 5,667 | -73 | -1.3% | 1,105,700 |
2018/06/21 | 5,749 | 5,801 | 5,727 | 5,740 | -41 | -0.7% | 847,100 |
2018/06/20 | 5,694 | 5,781 | 5,670 | 5,781 | +108 | +1.9% | 1,464,900 |
2018/06/19 | 5,797 | 5,808 | 5,662 | 5,673 | -122 | -2.1% | 1,347,400 |
2018/06/18 | 5,800 | 5,821 | 5,756 | 5,795 | +9 | +0.2% | 1,017,700 |
2018/06/15 | 5,745 | 5,844 | 5,735 | 5,786 | +75 | +1.3% | 1,769,600 |
2018/06/14 | 5,723 | 5,744 | 5,644 | 5,711 | -37 | -0.6% | 1,163,000 |
2018/06/13 | 5,775 | 5,794 | 5,722 | 5,748 | -11 | -0.2% | 654,100 |
2018/06/12 | 5,750 | 5,777 | 5,701 | 5,759 | +49 | +0.9% | 1,001,600 |
2018/06/11 | 5,667 | 5,730 | 5,659 | 5,710 | +65 | +1.2% | 764,700 |
2018/06/08 | 5,711 | 5,715 | 5,627 | 5,645 | -65 | -1.1% | 1,399,400 |
2018/06/07 | 5,730 | 5,749 | 5,700 | 5,710 | +65 | +1.2% | 1,274,300 |
2018/06/06 | 5,591 | 5,670 | 5,587 | 5,645 | +28 | +0.5% | 805,600 |
2018/06/05 | 5,670 | 5,717 | 5,591 | 5,617 | -81 | -1.4% | 1,297,300 |
2018/06/04 | 5,740 | 5,757 | 5,694 | 5,698 | -7 | -0.1% | 815,500 |
2018/06/01 | 5,736 | 5,799 | 5,703 | 5,705 | -9 | -0.2% | 1,367,800 |
2018/05/31 | 5,595 | 5,737 | 5,577 | 5,714 | +167 | +3% | 2,977,700 |
2018/05/30 | 5,519 | 5,573 | 5,519 | 5,547 | -103 | -1.8% | 1,411,300 |
2018/05/29 | 5,651 | 5,680 | 5,624 | 5,650 | +14 | +0.2% | 759,600 |
2018/05/28 | 5,684 | 5,688 | 5,620 | 5,636 | -35 | -0.6% | 725,900 |
2018/05/25 | 5,658 | 5,711 | 5,631 | 5,671 | +10 | +0.2% | 778,600 |
2018/05/24 | 5,637 | 5,667 | 5,613 | 5,661 | +19 | +0.3% | 973,700 |
2018/05/23 | 5,651 | 5,688 | 5,611 | 5,642 | -39 | -0.7% | 1,072,000 |
2018/05/22 | 5,709 | 5,716 | 5,649 | 5,681 | -67 | -1.2% | 791,400 |
2018/05/21 | 5,750 | 5,786 | 5,733 | 5,748 | -9 | -0.2% | 898,000 |
2018/05/18 | 5,777 | 5,777 | 5,725 | 5,757 | +3 | +0.1% | 1,004,800 |
2018/05/17 | 5,748 | 5,776 | 5,729 | 5,754 | +26 | +0.5% | 977,500 |
2018/05/16 | 5,704 | 5,737 | 5,690 | 5,728 | +5 | +0.1% | 790,100 |
2018/05/15 | 5,679 | 5,754 | 5,643 | 5,723 | -4 | -0.1% | 1,113,000 |
2018/05/14 | 5,747 | 5,763 | 5,719 | 5,727 | -13 | -0.2% | 980,100 |
2018/05/11 | 5,675 | 5,747 | 5,665 | 5,740 | +72 | +1.3% | 1,623,400 |
2018/05/10 | 5,577 | 5,677 | 5,510 | 5,668 | +191 | +3.5% | 1,716,600 |
2018/05/09 | 5,560 | 5,620 | 5,428 | 5,477 | -208 | -3.7% | 2,387,000 |
1551~
1600
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム